Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene Higher on Revlimid Patent Case Document Release
TheStreet.com
Wednesday, April 9, 2014 - 9:35pm
tags:
Celgene, Revlimid, patents
Ambit's Oncology Drug in Phase III
Yahoo/Zacks.com
Wednesday, April 9, 2014 - 9:34pm
tags:
Ambit Biosciences, quizartinib, acute myeloid leukemia
Why Does This Former Pharma King Keep Buying Shares Of Tribute Pharmaceuticals?
Seeking Alpha
Wednesday, April 9, 2014 - 9:29pm
tags:
Tribute Pharmaceuticals, John Gregory, Bezalip SR
Why The Federal Employees Health Benefits Letter Is A Big Deal For Belviq
Seeking Alpha
Wednesday, April 9, 2014 - 3:57pm
tags:
Belviq, obesity, HMOs, Arena Pharmaceuticals
Novartis, NEA join $188M gamble on China biotech fund
Fierce Biotech
Wednesday, April 9, 2014 - 11:51am
tags:
China, NEA, Novartis
Nektar reports positive preclinical data for two oncology programs
The Fly on the Wall
Wednesday, April 9, 2014 - 11:50am
tags:
Nektar, NKTR-102, NKTR-214, breast cancer
Almirall Drops on U.S. Regulator’s Scrutiny of Lung Drug
Bloomberg
Wednesday, April 9, 2014 - 11:28am
tags:
Almirall, FDA, Forest Labs, COPD, formoterol, aclidinium
Intuitive Quarterly Robot Sales Decline Almost by Half
Bloomberg
Wednesday, April 9, 2014 - 11:24am
tags:
Intuitive Surgical, devices, earnings
Gilead Sciences: Pricing Concerns Just Noise?
Barron's
Wednesday, April 9, 2014 - 11:17am
tags:
Gilead Sciences, Sovaldi, drug pricing, hepatitis C
VNRX: Clinical Data Looks Promising For Colon Cancer Opportunity
Yahoo/Zacks.com
Wednesday, April 9, 2014 - 10:27am
tags:
colon cancer, VolitionRX
More than three-quarters of patients think pharma companies have a responsibility to provide information and services that help patients manage their own health
E-week
Wednesday, April 9, 2014 - 9:11am
tags:
patients
Meet Spero, a biotech hopeful with Roche's blessing and a novel antibiotic
Fierce Biotech
Wednesday, April 9, 2014 - 9:02am
tags:
Roche, Spero, antibiotics, drug-resistant bacteria
Pfizer: It Never Rains, It Pours
Seeking Alpha
Wednesday, April 9, 2014 - 8:55am
tags:
Pfizer, Viagra, melanoma, Zyvox, Celebrex, patents
WHO joins clamour to make new hepatitis C pills affordable
Yahoo/Reuters
Wednesday, April 9, 2014 - 8:54am
tags:
WHO, hepatitis C, Sovaldi, Gilead Sciences
Merck Launches Hail Mary Lung Cancer Trial
Motley Fool
Wednesday, April 9, 2014 - 8:53am
tags:
Merck KGaA, tecemotide, Oncothyreon, non-small cell lung cancer
Tale Of Two Heart Drugs Show Challenges And Rewards In R&D
Forbes
Wednesday, April 9, 2014 - 8:51am
tags:
LCZ696, Novartis, heart failure, darapladib, R&D, heart disease, GSK
FDA halts Halozyme's pancreatic cancer study
Yahoo/Reuters
Wednesday, April 9, 2014 - 8:49am
tags:
pancreatic cancer, FDA, Halozyme
Eli Lilly and T1D to partner in diabetes research collaboration
The Fly on the Wall
Wednesday, April 9, 2014 - 8:48am
tags:
T1D, R&D, diabetes, Eli Lilly
Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S. - sources
Yahoo/Reuters
Wednesday, April 9, 2014 - 8:46am
tags:
Sun Pharma, Ranbaxy, M&A, generics
Big Pharma Opens New Chapter On Big Data Collaboration
Forbes
Wednesday, April 9, 2014 - 8:45am
tags:
Project Data Sphere, AstraZeneca, Bayer, Celgene, JNJ, Pfizer, Sanofi, clinical trial data

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.